Bain Capital Public Equity Management II, LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 114 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bain Capital Public Equity Management II, LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$5,084,000
+50.5%
1,412,279
+12.1%
0.48%
+54.8%
Q2 2019$3,378,0001,260,3790.31%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders